Regeneron Pharmaceuticals, Inc. (REGN) vs Roivant Sciences Ltd. (ROIV)
- Regeneron Pharmaceuticals, Inc. REGN 790.74 −0.70%
- Roivant Sciences Ltd. ROIV 33.53 −1.50%
Regeneron Pharmaceuticals, Inc. and Roivant Sciences Ltd. are both Biotechnology companies. Regeneron Pharmaceuticals, Inc. is the larger, with a market value of $82.0B against $24.6B — 3.3× the size. Roivant Sciences Ltd. has negative trailing earnings, so its P/E is not meaningful; Regeneron Pharmaceuticals, Inc. trades at 18.9×. Regeneron Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 9.29% against −67.6%. Regeneron Pharmaceuticals, Inc. has the higher net margin (27.9% vs −3,535.0%) and the higher return on invested capital (9.34% vs −34.5%). Across the 19 metrics below, Regeneron Pharmaceuticals, Inc. leads on 17 and Roivant Sciences Ltd. on 2.
Valuation
Profitability
| Metric | REGN | ROIV | Biotechnology median |
|---|---|---|---|
| Gross margin | 84.86% | 81.21% | 65.16% |
| Operating margin | 24.74% | (7,914.75%) | 0.00% |
| Net margin | 27.86% | (3,534.96%) | 0.00% |
| Free cash flow margin | 23.01% | (10,901.00%) | 0.00% |
| Return on equity | 14.04% | (5.47%) | (56.36%) |
| Return on assets | 10.83% | (5.15%) | (48.04%) |
| Return on invested capital | 9.34% | (34.51%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack